Crossmark

Clinical pharmacokinetics of 3-h extended infusion of meropenem in adult patients with severe sepsis and septic shock: implications for empirical therapy against Gram-negative bacteria

Crossref DOI link: https://doi.org/10.1186/s13613-019-0622-8

Published Online: 2020-01-10

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kothekar, Amol T.

Divatia, Jigeeshu Vasishtha https://orcid.org/0000-0001-7384-4886
Myatra, Sheila Nainan

Patil, Anand

Nookala Krishnamurthy, Manjunath

Maheshwarappa, Harish Mallapura

Siddiqui, Suhail Sarwar

Gurjar, Murari

Biswas, Sanjay

Gota, Vikram
Funding

Funding for this research was provided by:

Tata Memorial Centre (Intramural grant)
License Information

Text and Data Mining valid from 2020-01-10

Version of Record valid from 2020-01-10
More Information

Article History

Received: 10 September 2019

Accepted: 26 December 2019

First Online: 10 January 2020

Ethics approval and consent to participate

: The study was approved by the institutional review board. Written informed consent was taken from the patients or their legal representatives.

: Not applicable as the individual patient details, images or videos are not included.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below